The Diabetes and Metabolism group, led by Dr. Rafael Simó at Vall d’Hebron Institute of Research (VHIR), has been awarded with the 2014 grant of the "http://www.acdiabetis.org/index.php" Catalan Diabetes Association, for the project “Neuroprotection by GLP-1: preclinical development of a new therapeutic strategy for diabetic retinopathy”. The study aims to administer in mice with the diabetes murine model a neuroprotective eye drops drug, the GLP-1, to assess if the diabetes’ early retinal damage can be prevented. The study will start in the next weeks and the outcomes will be published next year. The Catalan Diabetes Association concedes the 10,000€ grant with the objective to support the development of clinical research projects that improve the knowledge of the disease and the medical attention to patients.